Join
Live feed
·
INSIDERFilingvia Quantisnow
Ovid Therapeutics Inc. logo

President and CEO Alexander Margaret A. sold $16,901 worth of shares (11,656 units at $1.45), decreasing direct ownership by 16% to 61,750 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track OVID (Ovid Therapeutics Inc.) and more on Quantisnow.